常用名 | 塔妥珠单抗 | CAS号 | 1826831-79-1 |
---|---|---|---|
价格 | 纯度 | 95.0% | |
备货期 | 10天 | 库存 | 现货 |
产品详情(用途,包装等)
用途: Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models[1][2][3][4]. 物理化学性质: CAS号:1826831-79-1 常用中文名:塔妥珠单抗 常用英文名:Talacotuzumab 分子式: 分子量: 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A |